Abnormal Expression of Cerebrospinal Fluid Cation Chloride Cotransporters in Patients with Rett Syndrome

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Duarte, Sofia Temudo ^a,c,d   Armstrong, Judith ^a,b   Roche, Ana ^a   Ortez, Carlos ^a,b   Pérez, Ana ^a   O'Callaghan, Maria del Mar ^a   Pereira, Antonina ^c   Sanmartí, Francesc ^a   Ormazábal, Aida ^a,b   Artuch, Rafael ^a,b   Pineda, Mercedes ^a,b   García Cazorla, Angels ^a,b  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; CATION CHLORIDE COTRANSPORTER; CATION TRANSPORT PROTEIN; POTASSIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CELL MATURATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; HUMAN; IMMUNOBLOTTING; MALE; NERVE CELL; NEWBORN; PERINATAL PERIOD; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; RETT SYNDROME; SCHOOL CHILD;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETT SYNDROME; SOLUTE CARRIER FAMILY 12, MEMBER 2; SYMPORTERS; YOUNG ADULT;

EID: 84880446973     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068851     Document Type: Article

References (35)

1. Hagberg B, Aicardi J, Dias K, Ramos O, (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett'ssyndrome: Report of 35 cases. Ann Neurol 14: 471-479.
2. Monteggia LM, Kavalali ET, (2009) Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission. Biol Psychiatry 65: 204-210.
3. Nissenkorn A, Gak E, Vecsler M, Reznik H, Menascu S, et al. (2010) Epilepsy in Rett syndrome-the experience of a National Rett Center. Epilepsia 51: 1252-1258.
4. Jellinger K, Armstrong D, Zoghbi HY, Percy AK, (1988) Neuropathology of Rett syndrome. Acta Neuropathol 76: 142-158.
5. Reiss AL, Faruque F, Naidu S, Abrams M, Beaty T, (1993) Neuroanatomy of Rett syndrome: a volumetric imaging study. Ann Neurol 34: 227-243.
6. Boggio EM, Lonetti G, Pizzorusso T, Giustetto M, (2010) Synaptic determinants of rett syndrome. Front Synaptic Neurosci 2: 28.
7. Kron M, Howell CJ, Adams IT, Ransbottom M, Christian D, et al. (2012) Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment. J Neurosci. 32: 13860-13872.
8. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, et al. (2010) Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468: 263-269.
9. Blaesse P, Airaksinen MS, Rivera C, Kaila K, (2009) Cation-chloride cotransporters and neuronal function. Neuron 61: 820-838.
10. Muñoz A, Méndez P, DeFelipe J, Alvarez-Leefmans FJ, (2007) Cation-chloride cotransporters and GABA-ergic innervation in the human epileptic hippocampus. Epilepsia 48: 663-673.
11. Woo NS, Lu JM, England R, McClellan R, Dufour S, et al. (2002) Hyperexcitability and epilepsy associated with disruption of the mouse neuronal-specific K-Cl cotransporter gene. Hippocampus 12: 258-268.
12. Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, et al. (2005) NKCC1 transporter facilitates seizures in the developing brain. Nat Med 11: 1205-1213.
13. Kahle KT, Barnett SM, Sassower KC, Staley KJ, (2009) Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. J Child Neurol 24: 572-576.
14. Lemonnier E, Degrez C, Phelep M, Tyzio R, Josse F, et al. (2012) A randomised controlled trial of bumetanide in the treatment of autism in children. Transl Psychiatry. 2: e202.
15. Wang H, Chan SA, Ogier M, Hellard D, Wang Q, et al. (2006) Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J Neurosci 26: 10911-10915.
16. Aguado F, Carmona MA, Pozas E, Aguiló A, Martínez-Guijarro FJ, et al. (2003) BDNF regulates spontaneous correlated activity at early developmental stages by increasing synaptogenesis and expression of the K+/Cl- co-transporter KCC2. Development 130: 1267-1280.
17. Carmona MA, Pozas E, Martínez A, Espinosa-Parrilla JF, Soriano E, et al. (2006) Age-dependent spontaneous hyperexcitability and impairment of GABAergic function in the hippocampus of mice lacking trkB. Cereb Cortex 16: 47-63.
18. Plotkin MD, Snyder EY, Hebert SC, Delpire E, (1997) Expression of the Na-K-2Cl cotransporter is developmentally regulated in postnatal rat brains: a possible mechanism underlying GABA's excitatory role in immature brain. J Neurobiol 33: 781-795.
19. Duarte ST, Ortez C, Pérez A, Artuch R, García-Cazorla A, (2011) Analysis of synaptic proteins in the cerebrospinal fluid as a new tool in the study of inborn errors of neurotransmission. J Inherit Met Dis 34: 523-528.
20. Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, et al. (2010) Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol. 68: 944-950.
21. Ormazábal A, García-Cazorla A, Fernández A, Fernández-Alvarez E, Campistol J, et al. (2005) HPLC with electrochemical and fluorescence detection procedures for the diagnosis of inborn errors of biogenic amines and pterins. J Neurosc Methods 142: 153-158.
22. Maroco J (2007) Análise Estatística com utilização do SPSS [Statistical analysis using SPSS] (3rd Ed). Lisbon, Portugal: Silabo.
23. Biou D, Benoist JF, Nguyen-Thi Xuan, Huong C, Huong X, et al. (2000) Cerebrospinal fluid protein concentrations in children: age-related values in patients without disorders of the central nervous system. Clin Chem 46: 399.
24. Galanopoulou AS, (2008) Sexually dimorphic expression of KCC2 and GABA function. Epilepsy Res 80: 99-113.
25. Thouvenot E, Urbach S, Dantec C, Poncet J, Séveno M, (2008) Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluid. J Proteome Res. 7: 4409-4421.
26. Harrington MG, Fonteh AN, Oborina E, Liao P, Cowan RP, et al. (2009) The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid. Cerebrospinal Fluid Res 6: 10.
27. Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH, (2004) Nanotubular highways for intercellular organelle transport. Science 303: 1007-1010.
28. Galanopoulou AS, (2008) GABA(A) receptors in normal development and seizures: friends or foes? Curr Neuropharmacol 6: 1-20.
29. Deng V, Matagne V, Banine F, Frerking M, Ohliger P, et al. (2006) FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet 16: 640-650.
30. Danglot L, Triller A, Marty S, (2006) The development of hippocampal interneurons in rodents. Hippocampus 16: 1032-1060.
31. Kline DD, Ogier M, Kunze DL, Katz DM, (2010) Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice. J Neurosci 30: 5303-5310.
32. Medrihan L, Tantalaki E, Aramuni G, Sargsyan V, Dudanova I, et al. (2008) Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol 299: 112-121.
33. Chao HT, Zoghbi HY, Rosenmund C, (2007) MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56: 58-65.
34. Zhang L, He J, Jugloff DG, Eubanks JH, (2008) The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 18: 294-309.
35. Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, et al. (2012) Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Ann Neurol 71: 539-51.